Fortitude Family Office »

Janux Therapeutics shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.4k 207 45.43
2024-06-30 $8.7k 207 41.89
2024-03-31 $7.8k 207 37.65
2023-12-31 $2.5k 237 10.73

More positions owned by Fortitude Family Office

Apple Stock (AAPL)
Knight-swift Transn Hldgs Inc Cl A Stock (KNX)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Vanguard Mid-cap Etf Etf (VO)
Ishares Tips Bond Etf Etf (TIP)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Ishares Core S&p Small Cap Etf Etf (IJR)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Avantis International Small Cap Value Etf Etf (AVDV)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Jpmorgan Ultra-short Income Etf Etf (JPST)
Kkr & Co Stock (KKR)

View all positions for Fortitude Family Office

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
Paradigm Biocapital Advisors
BlackRock
Henderson Group
Woodline Partners
Vanguard Group
EcoR1 Capital
State Street Corporation
OrbiMed Advisors
Citadel Advisors
Cormorant Asset Management
Logos Global Management
Lord, Abbett & Co
Geode Capital Management

View all funds holding Janux Therapeutics